Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
01/2008
01/01/2008US7314884 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile
01/01/2008US7314873 (Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents
01/01/2008US7314872 Selective in presence of at least one other cathepsin isozyme; such as morpholine-4-carboxylic acid {2-cyclopentyl-1--[2-(4-methoxy-phenylamino)-1--methyl-ethylcarbamoyl]-ethyl}-amide
12/2007
12/27/2007WO2007149568A2 N- (4-chl0r0-3-methyl-5-is0xaz0lyl) -2- [2-methyl-4, 5- (methylenedioxy) phenylacetyl] -thiophene-3-sulfonamide
12/27/2007WO2007149478A2 Pyrazine derivatives with extended conjugation and uses thereof
12/27/2007WO2007149448A2 Pyrazinones as cellular proliferation inhibitors
12/27/2007WO2007149395A2 2,5-substituted oxazole derivatives as protein kinase inhibitors for the treatment of cancer
12/27/2007WO2007149031A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases
12/27/2007WO2007149030A1 Novel heteroaryl substituted benzoxazoles
12/27/2007WO2007148780A1 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor
12/27/2007WO2007148738A1 Pest control agent containing novel pyridyl-methanamine derivative or salt thereof
12/27/2007WO2007147794A1 Furan derivatives and their use as antiviral agents
12/27/2007WO2007147778A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them
12/27/2007WO2007147514A1 Tablets comprising candesartan cilexetil
12/27/2007WO2007130821A3 Mglur5 modulators ii
12/27/2007WO2007120980A3 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
12/27/2007WO2007116229A8 Heterocyclic gpcr agonists
12/27/2007WO2007092751A3 Compounds and methods for modulating fx-receptors
12/27/2007WO2006129158B1 3 - indazolyl - isoxazoline derivatives as inhibitors of phosphodiesterase type - i
12/27/2007US20070299258 Therapeutic compounds and their use in cancer
12/27/2007US20070299092 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors
12/27/2007US20070299073 Imidazolyl derivatives
12/27/2007US20070299071 Substituted phenyl methanone derivatives
12/27/2007US20070299070 Such as 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-indole-2-carboxamide and 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-benzimidazole-2-carboxamide; melanin-concentrating hormone receptor antagonist, useful for treating obesity
12/27/2007US20070299069 Methods for treating hepatitis C
12/27/2007US20070299068 viricides comprising (3-cyano-indol-2-yl)phenyl derivatives, used for for treating viral diseases and infections or for affecting viral internal ribosome entry site (IRES) activity
12/27/2007US20070299067 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
12/27/2007US20070299066 Novel Pyrimidothienoindazoles
12/27/2007US20070299065 Tetrahydropyran Derivatives as Antidiabetics
12/27/2007US20070299063 N3 alkylated benzimidazole derivatives as mek inhibitors
12/27/2007US20070299060 (1R,2R,3S,4S)-5-fluoro-N4-[3- methylaminocarbonylbicyclo[2.2.1]hept-5- en-2-yl)-N2-[1-methylsulfonyl-2,3- dihydroindol-5-yl]-2,4-pyrimidinediamine, used to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers
12/27/2007US20070299059 Compostions and methods relating to novel compounds and targets thereof
12/27/2007US20070299057 Heterocyclic piperidines as modulators of chemokine receptor activity
12/27/2007US20070299056 Benzazepine derivatives for the treatment of neurological disorders
12/27/2007US20070299051 Tricyclic Guanidine Derivatives as Sodium-Proton Exchange Inhibitors
12/27/2007US20070299039 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
12/27/2007DE102006028649A1 New 5-quinoline derivatives are topoisomerase inhibitors useful to treat bacterial infections
12/27/2007CA2655857A1 Pyrazine derivatives with extended conjugation and uses thereof
12/27/2007CA2655084A1 Novel heteroaryl substituted benzoxazoles
12/27/2007CA2654689A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them
12/27/2007CA2654493A1 Tablets comprising candesartan cilexetil
12/26/2007EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors
12/26/2007EP1870099A1 Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
12/26/2007EP1869032A1 Pyrimidine derivatives for use as anticancer agents
12/26/2007EP1869031A1 Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor
12/26/2007EP1869030A1 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
12/26/2007EP1869029A1 An oxindole oxazolidinone as antibacterial agent
12/26/2007EP1869028A1 Pyrimidines as igf-i inhibitors
12/26/2007EP1869027A2 Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors
12/26/2007EP1869026A1 Novel compounds
12/26/2007EP1869020A1 HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl
12/26/2007EP1869019A1 Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors
12/26/2007EP1869018A1 3-triazolylthioalkyl-3-azabicyclo (3 - 1 - o) hexanes and their use as dopamine d3 receptor ligands
12/26/2007EP1869017A1 3- (1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors
12/26/2007EP1869000A1 Cyclopentapyridine and tetrahydroquinoline derivatives
12/26/2007EP1868998A2 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
12/26/2007EP1868997A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
12/26/2007EP1868607A2 Isoqunoline compounds and methods of use thereof
12/26/2007EP1597248B1 Sulfonamide derivatives as ppar modulators
12/26/2007EP1233769B1 Imidazole derivatives
12/26/2007CN101094848A Organic compounds
12/26/2007CN101094837A Novel beta agonists, method for producing the same and their use as drugs
12/26/2007CN101094834A Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
12/26/2007CN101092415A Compound of new benzo heterocycle categories, preparation method and application
12/26/2007CN100357290C Pesticidal 3-(substituted phenyl)-5-(thienyl or furyl)-1,2,4-triazoles
12/26/2007CN100357281C Bicyclic compounds, process for their preparation and pharmaceutical composition containing them
12/26/2007CN100357280C Dihydronaphthalene devivatives and drugs contanining these compounds as active ingrdeient
12/26/2007CN100357278C Substituted triazole diamine derivatives as kinase inhibitors
12/26/2007CN100357276C Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors
12/26/2007CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
12/26/2007CN100357273C Process for the production of substituted nicotinic acid esters
12/26/2007CN100357270C D-proline derivative
12/26/2007CN100356984C 整联蛋白靶向的影像剂 Integrin targeting imaging agent
12/26/2007CN100356917C Carboxylic and substituted oxazole derivatives for use as PPAR-& and PPAR-r activators in the treatment of diabetes
12/26/2007CN100356916C Pharmaceutical compositions
12/25/2007US7312339 cytotoxic agents; made by fermentation of Streptomyces sparsogenes
12/25/2007US7312336 Ligands for the delta opiod receptor; novel compounds which possess a piperidine ring with an exocyclic double bond do not show significant convulsive effects when administered systemically
12/25/2007US7312234 Chemokine receptor binding heterocyclic compounds
12/25/2007US7312222 Heterocyclic piperidines as modulators of chemokine receptor activity
12/25/2007US7312221 Therapeutic treatment of endotoxic shock with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating psoriasis, arthritis, osteoarthritis, glomerulonephriti, autoimmune disorder include diabetes, asthma, or multiple sclerosis
12/25/2007US7312220 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/25/2007US7312218 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide
12/25/2007US7312215 Anticancer agents
12/25/2007US7312211 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis
12/25/2007US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/25/2007US7312200 9-ketospinosyn derivatives
12/21/2007WO2007146981A2 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
12/21/2007WO2007145563A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007WO2007143824A1 Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007WO2007143823A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007WO2007118323B1 Isoxazole derivatives as calcium channel blockers
12/21/2007WO2007117607A3 Quinazolines for pdk1 inhibition
12/21/2007WO2007085451A3 3,5-di (aryl or heteroaryl) isoxazoles and 1, 2, 4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti -inflammatory agents
12/21/2007WO2007062078A3 Thrombopoietin activity modulating compounds and methods
12/21/2007WO2007059359A3 Substituted pyrazalones
12/21/2007WO2007001225A8 Thiophene-2-carboxamide derivatives as alpha 7 nicotinic receptor modulators.
12/21/2007WO2005030712A8 Thrombin receptor antagonists
12/21/2007CA2655106A1 Substituted gamma lactams as therapeutic agents
12/21/2007CA2654792A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
12/21/2007CA2654515A1 Substituted 3-cyanopyridines as protein kinase inhibitors
1 ... 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 ... 647